Unmodified and phosphorylated prolactin and gamma delta T cell development and function.

Abstract:

:This manuscript discusses our studies to date concerning the effects of unmodified prolactin (PRL) and phosphorylated PRL on immune function. Most of the discussion refers to effects of changing the ratio of these two forms in maternal PRL on gamma delta T cell development in rat pups in utero, but limited experiments where adult animals have been directly treated are also discussed. The manuscript begins with some general background on gamma delta T cells and the different forms of PRL and then proceeds to a discussion of experimental findings. Results demonstrate that the ratio of unmodified to phosphorylated PRL during rat pregnancy is crucial to normal epidermal gamma delta T cell development in the pup thymus. Elevation of phosphorylated PRL in the dams, by administration of a recombinant molecular mimic of phosphorylated PRL, produces a defect in epidermalgamma delta T cell seeding and subsequent function in the offspring. In contrast, a functional defect is not seen for uterine gamma delta T cells in the offspring, a finding likely reflective of the continued availability of precursors to these cells after the fetal period. Preliminary results from treatment of the NZB/NZW mouse model of lupus with the two forms of PRL suggest opposing effects of unmodified and phosphorylated PRL on one measure of the disease.

journal_name

Lupus

journal_title

Lupus

authors

Walker AM

doi

10.1191/096120301717164976

subject

Has Abstract

pub_date

2001-01-01 00:00:00

pages

735-41

issue

10

eissn

0961-2033

issn

1477-0962

journal_volume

10

pub_type

杂志文章,评审

相关文献

LUPUS文献大全
  • Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis.

    abstract::This study assessed the expression of complement receptor 1 (CR1), decay accelerating factor (DAF) and membrane inhibitor of reactive lysis (CD59) on the erythrocytes and glomerulus of diffuse proliferative glomerulonephritis (DPGN) of systemic lupus erythematosus (SLE) patients using flow cytometry and immunofluoresc...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120300678828154

    authors: Arora M,Arora R,Tiwari SC,Das N,Srivastava LM

    更新日期:2000-01-01 00:00:00

  • Antiphospholipid syndrome: clinical and therapeutic aspects.

    abstract::The purpose of the present study was to evaluate patients with the antiphospholipid syndrome with particular attention to their initial clinical features, final diagnoses and the course of thrombotic events in association with therapy. The methodology applied was the following: retrospective analysis of 30 patient fil...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300206

    authors: Vlachoyiannopoulos PG,Tsiakou E,Chalevelakis G,Raptis SA,Moutsopoulos HM

    更新日期:1994-04-01 00:00:00

  • Towards evidence-based treatment of thrombotic antiphospholipid syndrome.

    abstract::Thrombosis in the presence of persistently positive tests for antiphospholipid antibodies is termed thrombotic antiphospholipid syndrome (APS). At present, 'standard' secondary thromboprophylaxis in thrombotic APS is treatment with moderate intensity oral anticoagulants for life after a first venous thrombosis and wit...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309361483

    authors: Derksen RH,de Groot PG

    更新日期:2010-04-01 00:00:00

  • Idiopathic intracranial hypertension as a significant cause of intractable headache in patients with systemic lupus erythematosus: a 15-year experience.

    abstract:OBJECTIVE:To evaluate the occurrence of idiopathic intracranial hypertension (IIH) in patients with systemic lupus erythematosus (SLE) and to describe the manifestations, treatments and outcomes in these patients. METHODS:We reviewed the medical records of 1084 patients with SLE followed up from January 1997 to June 2...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311435267

    authors: Kim JM,Kwok SK,Ju JH,Kim HY,Park SH

    更新日期:2012-04-01 00:00:00

  • Eosinophilic enteritis in association with systemic lupus erythematosus.

    abstract::Eosinophilic gastroenteritis (EGE) is an uncommon disease and has rarely been reported in association with connective tissue diseases as systemic lupus erythematosus. We report a 36-year-old woman who developed recurrent episodes of abdominal pain, nausea, vomiting and melena. Complete blood counts showed elevated eos...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308097573

    authors: Jaimes-Hernandez J,Aranda-Peirera P,Melendez-Mercado CI

    更新日期:2009-04-01 00:00:00

  • Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.

    abstract:OBJECTIVE:The feed-forward loop of type I interferons (IFNs) production and subsequent immunopathology of systemic lupus erythematosus (SLE) has been hypothesised to be disrupted with inhibition of IFNα or type I IFN receptor subunit 1 (IFNAR). This systematic review and meta-analysis present the treatment efficacy and...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320959702

    authors: Koh JWH,Ng CH,Tay SH

    更新日期:2020-12-01 00:00:00

  • Pathogenesis of the antiphospholipid antibody syndrome.

    abstract::Endothelial and/or platelet activation likely initiates thrombus formation. Whether antiphospholipid antibody (aPL) is an activator, a toxic response, or a protective response is not clear, nor is it certain whether aPL is germ-line encoded or antigen-driven. The pregnancy model is particularly informative. Alternativ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500514

    authors: Lockshin MD

    更新日期:1996-10-01 00:00:00

  • Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.

    abstract::Systemic lupus erythematosus (SLE) is characterized by multiple autoantibodies and complement activation. Recent studies have suggested that anti-nuclear antibody (ANA) positivity may disappear over time in some SLE patients. Anti-double-stranded DNA (dsDNA) antibody titers and complement levels may vary with time and...

    journal_title:Lupus

    pub_type: 历史文章,杂志文章

    doi:10.1177/0961203310385738

    authors: Ippolito A,Wallace DJ,Gladman D,Fortin PR,Urowitz M,Werth V,Costner M,Gordon C,Alarcón GS,Ramsey-Goldman R,Maddison P,Clarke A,Bernatsky S,Manzi S,Bae SC,Merrill JT,Ginzler E,Hanly JG,Nived O,Sturfelt G,Sanchez-Gu

    更新日期:2011-03-01 00:00:00

  • Invasive fungal infections in patients with systemic lupus erythematosus: experience from affiliated hospitals of Catholic University of Korea.

    abstract::The purpose of study was to determine the nature, outcomes and associated risk factors of invasive fungal infection (IFI) in patients with systemic lupus erythematosus (SLE), and compare the incidence of IFI in patients with rheumatoid arthritis (RA). A total of 1155 patients with SLE and 2004 patients with RA were re...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309103081

    authors: Kim HJ,Park YJ,Kim WU,Park SH,Cho CS

    更新日期:2009-06-01 00:00:00

  • Extrahepatic manifestations in chronic hepatitis C virus carriers.

    abstract::Patients with chronic hepatitis C virus (HCV) infection frequently present with extrahepatic manifestations covering a large spectrum, involving different organ systems leading to the concept of systemic HCV infection. These manifestations include autoimmune phenomena and frank autoimmune and/or rheumatic diseases and...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314556140

    authors: Rosenthal E,Cacoub P

    更新日期:2015-04-01 00:00:00

  • The role of endothelial dysfunction in the pathogenesis of neuropsychiatric systemic lupus erythematosus.

    abstract::Neuropsychiatric manifestations of systemic lupus erythematosus are common and disabling yet their pathogenesis is poorly understood. We investigated the role of cerebrovascular endothelial dysfunction in systemic lupus erythematosus and its neuropsychiatric manifestations. Subjects with systemic lupus erythematosus w...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309359780

    authors: Davey R,Bamford J,Emery P

    更新日期:2010-06-01 00:00:00

  • Impaired sexual function in women with systemic lupus erythematosus: a cross-sectional study.

    abstract:OBJECTIVE:The objectives of this paper are to compare sexual function and distress in women with systemic lupus erythematosus (SLE) and in healthy controls; to determine the association between disease characteristics, quality of life, psychopathology and sexual function; and to compare sexual function and distress of ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313500370

    authors: García Morales M,Callejas Rubio JI,Peralta-Ramírez MI,Henares Romero LJ,Ríos Fernández R,Camps García MT,Navarrete Navarrete N,Ortego Centeno N

    更新日期:2013-09-01 00:00:00

  • Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells.

    abstract::Previous studies in our laboratory showed a dose-dependent and hormone-specific increase in CD154 expression in T cells from females with systemic lupus erythematosus (SLE). This present study investigates if the estrogen-dependent increase in CD154 expression is due to stabilization of the messenger RNA. T cells from...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203306071314

    authors: Li X,Rider V,Kimler BF,Abdou NI

    更新日期:2006-01-01 00:00:00

  • Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.

    abstract:INTRODUCTION:High-mobility group box 1 protein (HMGB-1) has been implicated in the pathogenesis of lupus nephritis (LN). There is increased HMGB-1 expression in the kidneys and increased levels are observed in serum and urine of patients with LN. This study was performed to determine whether the increased urinary HMGB-...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316644331

    authors: Jog NR,Blanco I,Lee I,Putterman C,Caricchio R

    更新日期:2016-12-01 00:00:00

  • Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus.

    abstract:OBJECTIVE:This study aimed to explore the risk factors for 'severe' neuropsychiatric (NP) flare in patients with systemic lupus erythematosus (SLE). METHODS:This retrospective study comprised newly diagnosed 184 adult SLE patients who visited Hokkaido University Hospital between 2006 and 2017. In this study, severe NP...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320938453

    authors: Aso K,Kono M,Kono M,Watanabe T,Shimizu Y,Ogata Y,Fujieda Y,Kato M,Oku K,Amengual O,Yasuda S,Atsumi T

    更新日期:2020-09-01 00:00:00

  • Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases.

    abstract::The complexity of the therapeutic approach in systemic lupus erythematosus (SLE) is increased by the large number of patients who do not respond to the first-line therapies and by relapses after initial clinical remission. In these patients, second-line drugs are often prescribed according to individual clinical decis...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203309106174

    authors: Ramos-Casals M,Soto MJ,Cuadrado MJ,Khamashta MA

    更新日期:2009-08-01 00:00:00

  • Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients.

    abstract::The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (ACR) Damage Index (SDI) is an accepted instrument to ascertain damage. It has been shown to vary among different SLE populations. The aim of this study was to assess SDI score, pattern and factors related to damage in Brazilian SL...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu447xx

    authors: Soares M,Reis L,Papi JA,Cardoso CR

    更新日期:2003-01-01 00:00:00

  • Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry).

    abstract:BACKGROUND:Systemic lupus erythematosus (SLE) is regarded as a prototype autoimmune disease because it can serve as a means for studying differences between ethnic minorities and sex. Traditionally, all Hispanics have been bracketed within the same ethnic group, but there are differences between Hispanics from Spain an...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203319889667

    authors: Hernández Cruz B,Alonso F,Calvo Alén J,Pego-Reigosa JM,López-Longo FJ,Galindo-Izquierdo M,Olivé A,Tomero E,Horcada L,Uriarte E,Erausquin C,Sánchez-Atrio A,Montilla C,Santos Soler G,Fernández-Nebro A,Blanco R,Rodríguez-Góm

    更新日期:2020-01-01 00:00:00

  • The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjogren's syndrome.

    abstract::This study was designed to investigate whether Foxp3( +) regulatory T (Treg) cells play a role in the histopathologic changes of primary Sjögren's Syndrome (pSS) and to evaluate other factors possibly associated with Foxp3(+) Treg cells in pSS patients. The number of FoxP3-expressing T cells in peripheral blood (PB) o...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309348234

    authors: Sarigul M,Yazisiz V,Bassorgun CI,Ulker M,Avci AB,Erbasan F,Gelen T,Gorczynski RM,Terzioglu E

    更新日期:2010-02-01 00:00:00

  • Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.

    abstract:OBJECTIVE:The objective of this paper is to evaluate whether the different International Society of Nephrology/Renal Pathology Society (ISN/RPS) classes of proliferative lupus nephritis (LN) have a distinct baseline presentation, short-term response to immunosuppression (IS) and long-term prognosis. METHODS:Ninety-eig...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313514623

    authors: Vandepapelière J,Aydin S,Cosyns JP,Depresseux G,Jadoul M,Houssiau FA

    更新日期:2014-02-01 00:00:00

  • Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.

    abstract::The objective was to investigate the relation between serum levels of interferon-alpha (IFN-alpha), the activity of an endogenous IFN-alpha inducing factor (SLE-IIF), clinical and immunological disease activity as well as serum levels of antiretroviral antibodies in SLE. Serum levels of IFN-alpha were measured in seri...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120300674499064

    authors: Bengtsson AA,Sturfelt G,Truedsson L,Blomberg J,Alm G,Vallin H,Rönnblom L

    更新日期:2000-01-01 00:00:00

  • Reflections on the management of reproductive failure in the antiphospholipid syndrome--the clinician's perspective.

    abstract::It is well known that women with systemic lupus erythematosus (SLE) who have antiphospholipid antibodies (aPL) are at increased risk for pregnancy loss. Additionally, other reproductive processes, such as unexplained infertility and implantation failure after in vitro fertilization and embryo transfer may be affected ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu237ra

    authors: Balasch J,Cervera R

    更新日期:2002-01-01 00:00:00

  • Safety and efficacy of thrombopoeitin mimetics for refractory immune thrombocytopenia purpura in patients with systemic lupus erythematosus or antiphospholipid syndrome: a case series.

    abstract::Background While thrombopoeitin (TPO) agonists that act to simulate platelet production have been approved for use in steroid-refractory chronic immune thrombocytopenia purpura (ITP), there are few data on the safety and efficacy of these medications in patients with concurrent systemic lupus erythematosus (SLE) or an...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318770023

    authors: Lusa A,Carlson A

    更新日期:2018-09-01 00:00:00

  • Acute sideroblastic anemia in active systemic lupus erythematosus.

    abstract::This work describes the development of sideroblastic anemia (SA) during the clinical activity of systemic lupus erythematosus (SLE) in two patients. The cases refer to two women with SLE who developed SA during a relapse of the illness. Both patients fulfilled at least four criteria of the American Association of Rheu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300305

    authors: Jiménez-Balderas FJ,Morales-Polanco MR,Gutierrez L

    更新日期:1994-06-01 00:00:00

  • Objectively measured physical activity and its influence on physical capacity and clinical parameters in patients with primary Sjögren's syndrome.

    abstract::Objective The objectives of this paper are to objectively measure habitual physical activity levels in patients with primary Sjögren's syndrome (pSS) with mild disease activity and to determine to which extent it may be associated with physical capacity and function and clinical features. Methods In this cross-section...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316674819

    authors: Dassouki T,Benatti FB,Pinto AJ,Roschel H,Lima FR,Augusto K,Pasoto S,Pereira RMR,Gualano B,de Sá Pinto AL

    更新日期:2017-06-01 00:00:00

  • Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome.

    abstract::Autoantibodies against prothrombin, including lupus anticoagulant antibodies (LAC), have been identified in patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). To identify the epitopes of LAC in patients with SLE and APS, we analyzed B cell epitopes of anti-prothrombin Abs. Prothrombi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678840963

    authors: Akimoto T,Akama T,Kono I,Sumida T

    更新日期:1999-01-01 00:00:00

  • Chronic intestinal pseudo-obstruction: a rare first manifestation of systemic lupus erythematosus.

    abstract::Chronic intestinal pseudo-obstruction (CIPO) is a rare clinical syndrome of ineffective intestinal motility characterised by clinical and radiological evidence of intestinal obstruction with no identifiable mechanical lesion. CIPO can either be idiopathic or secondary to a systemic disease, like systemic lupus erythem...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203313492873

    authors: Khairullah S,Jasmin R,Yahya F,Cheah TE,Ng CT,Sockalingam S

    更新日期:2013-08-01 00:00:00

  • GATA3 rs3824662 gene polymorphism as possible risk factor for systemic lupus erythematosus.

    abstract:BACKGROUND:There is no report about the association between GATA3 rs3824662 polymorphism and systemic lupus erythematosus (SLE). OBJECTIVE:To investigate the possible role of GATA3 rs3824662 polymorphism as a susceptibility risk factor for either adult SLE (aSLE) or pediatric SLE (pSLE) and to evaluate its role in the...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318804894

    authors: Mosaad YM,Hammad A,Elghzaly AA,Tawhid ZME,Hammad EM,Showma A,Abdelsalam R,Elmoughy A,Fawzy IM,Anber N

    更新日期:2018-11-01 00:00:00

  • Effect of beta 2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system.

    abstract::The effect of beta 2glycoprotein I (beta 2GPI) and human monoclonal anticardiolipin antibody (aCL) on the protein S/C4b-binding protein (C4BP) system was evaluated. The binding of C4BP to protein S was assessed by ELISA in the presence of beta 2GPI with/without human monoclonal aCL. beta 2GPI downregulated the binding...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600403

    authors: Atsumi T,Khamashta MA,Ames PR,Ichikawa K,Koike T,Hughes GR

    更新日期:1997-01-01 00:00:00

  • Tacrolimus is an effective treatment for lupus nephritis in pregnancy.

    abstract::Lupus nephritis during pregnancy increases morbidity and mortality for mother and baby. Flares are difficult to treat as many therapeutic options are teratogenic or fetotoxic. Steroids alone may be unable to control disease activity and are associated with higher rates of preterm delivery, sepsis and gestational diabe...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314540353

    authors: Webster P,Wardle A,Bramham K,Webster L,Nelson-Piercy C,Lightstone L

    更新日期:2014-10-01 00:00:00